From muscle wasting to sarcopenia and myopenia: update 2012
about
Nutritional Deficiency in Patients with Heart FailureSarcopenia, Frailty, and Diabetes in Older AdultsLoss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatmentTestosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?Ghrelin.Novel insights on nutrient management of sarcopenia in elderlyThe cellular and molecular bases of leptin and ghrelin resistance in obesity.Aging-related changes in the iron status of skeletal muscleAre we closer to having drugs to treat muscle wasting disease?Effects of elastic resistance exercise on body composition and physical capacity in older women with sarcopenic obesity: A CONSORT-compliant prospective randomized controlled trial.Frailty consensus: a call to action.Quantitative ultrasound: measurement considerations for the assessment of muscular dystrophy and sarcopenia.Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention.Muscle wasting: an overview of recent developments in basic research.Moving on up: the Journal of Cachexia, Sarcopenia and Muscle.Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.Age-related variation in health status after age 60.The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin ReceptorHigher Protein Intake Is Associated with Higher Lean Mass and Quadriceps Muscle Strength in Adult Men and Women.Rapid screening for sarcopeniaBody composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study.The transcriptional coactivator PGC-1α is dispensable for chronic overload-induced skeletal muscle hypertrophy and metabolic remodeling.Effect of the Lipoxygenase Inhibitor Baicalein on Muscles in Ovariectomized Rats.From sarcopenia to frailty: a road less traveled.Sarcopenia: describing rather than defining a condition.Muscle wasting disease: a proposal for a new disease classification.Where frailty meets diabetes.Osteosarcopenia: where bone, muscle, and fat collide.Gait speed and cognitive score in elderly users of the primary care service.Welcome to the ICD-10 code for sarcopenia.Moving upwards - the journal of cachexia, sarcopenia and muscle in 2016.Improvement of skeletal muscle performance in ageing by the metabolic modulator TrimetazidineRecent developments in the treatment of heart failure: highlights from the American Heart Association's Scientific Sessions, Los Angeles, California, 3 - 7 December 2012.Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017.Negative effect of clenbuterol on physical capacities and neuromuscular control of muscle atrophy in adult rats.Sarcopenia assessment project in the nursing homes in Turkey.Effects of elastic band exercise on lean mass and physical capacity in older women with sarcopenic obesity: A randomized controlled trial.Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).Review of Epidemiology, Diagnosis, and Treatment of Osteosarcopenia in Korea.Osteosarcopenia
P2860
Q26741764-1F4A219E-BECB-4EF1-8F34-304457C7D2CCQ26751445-4B46E53F-68D8-4084-933E-8CD3A54870E3Q26775254-EC0C82CF-EACE-447E-9A60-DE910550ACEAQ28068397-11DF20F8-2EDE-4453-8316-A0F007F706CFQ28081062-0376101F-014B-454A-8D8F-0381147BE36CQ28387785-F4F78607-2B96-4F5F-8873-7871978018A3Q30235588-E945A572-2D68-47BD-914A-0D91DB0B42A7Q30273911-E9A56516-5C8C-40DC-A852-C85C5CC6EB05Q33741103-01CB635D-D59B-4574-BB88-FE0BE7EF89A9Q33783483-93202555-5B73-493C-9E4C-34E4E0EEC6CEQ33855832-5B8954E8-2D26-464E-8D57-1FE902E4AF1AQ33891261-692456EF-1353-45AE-9ADE-2BDB1A299869Q34156932-43435E00-C5ED-4FD7-9418-0E5DC39A02FFQ34156942-3071F8BB-0749-42DE-A941-00BC95C68A3AQ34495485-8815160C-3E62-4AFF-B221-6C46B5388B6DQ34591010-EB6C2DC4-E995-43F9-BF49-543BD4EEC6AAQ35143927-2E78179D-5766-429F-8975-0EC10E7D2381Q35596484-4FF15719-19E4-4D6B-804B-9F3F6B3219E6Q35775124-6D451EBD-BC52-4B49-85A5-32C9694CA0B6Q36349343-7619E0B7-AAB6-4262-9CEA-B0DA7F07CB57Q36357809-0F2C9660-7053-489B-B12F-577C8244ABB2Q37395056-02FEEEDB-5826-4254-8258-CF4FB931797DQ37512688-F1CF1AB1-6E9E-43CB-95EA-CE92A239554DQ37635894-CEFF6FEA-A3F5-4924-BFA6-054FC625A831Q38237001-81D918CF-7BB3-4F9E-B2FF-6DDDEFC283D0Q38268470-6E5A9EEE-C4EF-4233-9F75-E7321928B7BAQ38603449-CD49BE8D-3AE7-4790-8A84-D4329734DCA1Q39451458-0C8167A9-288D-4037-B348-A6DA5DF76A6FQ40202837-E827B7A0-9D03-46B8-9652-50A6BAC70F0DQ42366308-46B3A3DB-6885-4FCE-82D0-7465B8010B56Q42398018-7B302327-10FC-4590-999E-DB35B76BEEF7Q42793119-0A2B8733-56FF-4DA5-8125-A3146A8DA90FQ45167299-2A045E4B-0D77-421B-9D23-383E3C96988AQ46213438-902EC19A-4E52-42FA-9D4F-D38E49D1EB77Q47774494-223FAE34-E203-4150-AE0B-4E2A82254ABAQ48084934-3D62C028-F736-4507-B97F-2F93669C8CF7Q49358454-ECD19485-B056-4BE9-BE7A-01A7D4986446Q52861755-9D72BD87-2377-47DC-82C4-CAB15DAC01BCQ55283319-38C7B111-AAA1-4B9B-94CA-155C2238EE5CQ57416794-C76BD05F-442F-454D-AAF1-74DB1FF99EF2
P2860
From muscle wasting to sarcopenia and myopenia: update 2012
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
From muscle wasting to sarcopenia and myopenia: update 2012
@ast
From muscle wasting to sarcopenia and myopenia: update 2012
@en
type
label
From muscle wasting to sarcopenia and myopenia: update 2012
@ast
From muscle wasting to sarcopenia and myopenia: update 2012
@en
prefLabel
From muscle wasting to sarcopenia and myopenia: update 2012
@ast
From muscle wasting to sarcopenia and myopenia: update 2012
@en
P2860
P1476
From muscle wasting to sarcopenia and myopenia: update 2012
@en
P2093
John E Morley
P2860
P2888
P304
P356
10.1007/S13539-012-0089-Z
P577
2012-12-01T00:00:00Z